Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 5 March 2009, Vol. 113, No. 10, pp. 2229-2237.
Prepublished online as a Blood First Edition Paper on November 14, 2008; DOI 10.1182/blood-2008-04-153304.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2008-04-153304v1
113/10/2229    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jirmanova, L.
Right arrow Articles by Ashwell, J. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jirmanova, L.
Right arrow Articles by Ashwell, J. D
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 21, 2008
Accepted November 3, 2008

Genetic disruption of p38{alpha} Tyr-323 phosphorylation prevents TCR-mediated p38{alpha} activation and impairs IFN-{gamma} production

Ludmila Jirmanova, Dandapantula N Sarma, Dragana Jankovic, Paul R Mittelstadt, and Jonathan D Ashwell*

Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States

* Corresponding author; email: jda{at}pop.nci.nih.gov.

T cells possess a p38 activation alternative pathway in which stimulation via the antigen receptor (TCR) induces phosphorylation of p38{alpha} and {beta} on Tyr-323. To assess the contribution of this pathway to normal T cell function, we generated p38{alpha} "knock-in" mice in which Tyr-323 was replaced with Phe (p38{alpha}Y323F). TCR-mediated stimulation failed to activate p38{alpha}Y323F as measured by phosphorylation of the Thr-Glu-Tyr activation motif and p38{alpha} catalytic activity. Cell cycle entry was delayed in TCR-stimulated p38{alpha}Y323F T cells, which also produced less IFN-{gamma} than wild type T cells in response to TCR-mediated but not TCR-independent stimuli. p38{alpha}Y323F mice immunized with T helper 1 (Th1)-inducing antigens generated normal Th1 effector cells, but these cells produced less IFN-{gamma} than wild type cells when stimulated through the TCR. Thus, the Tyr-323-dependent pathway and not the classic MAP kinase cascade is the physiologic means of p38{alpha} activation through the TCR, and is necessary for normal Th1 function but not Th1 generation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020